Current with changes from the 2024 Legislative Session
Section 13-5303 - Dispensing procedure(a) At the time of dispensing nPEP, a pharmacist registered with the Program shall: (1) Screen the patient to determine that HIV exposure occurred within 72 hours before the dispensing;(2) Determine whether the patient meets clinical criteria consistent with the most recent CDC Guidelines, including : (i) The identification of any contraindicated medications; and(ii) If applicable, exposure as the result of an alleged rape or sexual offense or alleged child sexual abuse;(3) Subject to subsection (b) of this section, determine whether an available standing order is appropriate for the patient and dispense nPEP in accordance with the most recent CDC Guidelines;(4) Refer the patient to a disease intervention specialist within the Department for ongoing treatment; and(5) Determine whether the patient has a primary care provider and:(i) If the patient has a primary care provider, notify the provider that the patient was dispensed nPEP; or(ii) If the patient does not have a primary care provider, provide the patient with a list of local primary care providers and clinics provided by the Department.(b) If an available standing order is not appropriate for the patient, the pharmacist shall refer the patient to a primary care provider.(c) A pharmacist may dispense nPEP in accordance with a therapy management contract under Title 12, Subtitle 6A of the Health Occupations Article.Added by 2024 Md. Laws, Ch. 753,Sec. 1, eff. 10/1/2024.